$7,599.00
In Stock
Zepzelca is a medicine with the active substance lurbinectedin, indicated for the treatment of adult patients suffering from relapsed or refractory diffuse large B-cell lymphoma (DLBCL). This type of non-Hodgkin lymphoma is characterized by the rapid development of abnormal B cells. The drug works by targeting the BCL-2 protein, which plays a key role in preventing cancer cell death. By targeting BCL-2, the drug helps destroy cancer cells.
Active ingredient: lurbinectedin
Prescription medicine
